Wall Street analysts forecast that Aspen Aerogels Inc (NYSE:ASPN) will announce earnings of ($0.13) per share for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Aspen Aerogels’ earnings. The highest EPS estimate is ($0.11) and the lowest is ($0.14). Aspen Aerogels reported earnings per share of ($0.25) during the same quarter last year, which would suggest a positive year over year growth rate of 48%. The firm is scheduled to report its next earnings report on Thursday, February 22nd.
According to Zacks, analysts expect that Aspen Aerogels will report full-year earnings of ($0.88) per share for the current year, with EPS estimates ranging from ($0.89) to ($0.86). For the next financial year, analysts forecast that the firm will post earnings of ($0.38) per share, with EPS estimates ranging from ($0.41) to ($0.35). Zacks’ EPS averages are an average based on a survey of analysts that cover Aspen Aerogels.
Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Thursday, November 2nd. The construction company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.14) by $0.01. The company had revenue of $27.20 million during the quarter, compared to analyst estimates of $28.23 million. Aspen Aerogels had a negative return on equity of 21.86% and a negative net margin of 22.72%. The business’s revenue was down 8.1% on a year-over-year basis. During the same quarter last year, the firm earned ($0.13) EPS.
Shares of Aspen Aerogels (NYSE ASPN) traded down $0.03 on Monday, hitting $5.00. The stock had a trading volume of 65,652 shares, compared to its average volume of 24,592. The firm has a market cap of $117.00, a price-to-earnings ratio of -5.00 and a beta of 1.09. Aspen Aerogels has a one year low of $3.84 and a one year high of $5.20.
In other news, major shareholder Craig A. Huff sold 2,895,981 shares of Aspen Aerogels stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $4.30, for a total value of $12,452,718.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 16.80% of the stock is currently owned by company insiders.
Several institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. grew its position in shares of Aspen Aerogels by 0.5% in the 2nd quarter. Vanguard Group Inc. now owns 582,689 shares of the construction company’s stock worth $2,592,000 after acquiring an additional 3,158 shares in the last quarter. Reservoir Operations L.P. grew its position in shares of Aspen Aerogels by 0.4% in the 3rd quarter. Reservoir Operations L.P. now owns 2,908,270 shares of the construction company’s stock worth $12,651,000 after acquiring an additional 12,289 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Aspen Aerogels by 384.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 80,149 shares of the construction company’s stock worth $349,000 after acquiring an additional 63,605 shares in the last quarter. Mesirow Financial Investment Management Inc. bought a new stake in shares of Aspen Aerogels in the 2nd quarter worth approximately $330,000. Finally, Royce & Associates LP lifted its holdings in shares of Aspen Aerogels by 12.8% in the 3rd quarter. Royce & Associates LP now owns 660,746 shares of the construction company’s stock worth $2,874,000 after purchasing an additional 74,792 shares during the last quarter. Institutional investors own 74.40% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “” was first published by Markets Daily and is owned by of Markets Daily. If you are reading this article on another publication, it was stolen and republished in violation of United States and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.themarketsdaily.com/2018/01/19/1226946.html.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in energy infrastructure facilities. The Company also performs contract research services for various federal and non-federal government agencies, including the Department of Defense, the Department of Energy and other institutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.